COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Market: Pharmaceuticals and Healthcare

Asia Pacific, 122 pages report, published by GBI Research

Report ThumbnailJanuary-2017
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Summary

Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of chronic morbidity and mortality globally. Many peopl

Read More
  • 1.2 List of Figures
  • Figure 1: COPD Therapeutics Market, Treatment Algorithm of COPD 17
  • Figure 2: COPD Market, Global, Moderate-to-Severe COPD Marketed Products Heat Map, Efficacy, 2016 32
  • Figure 3: COPD Market, Global, Moderate-to-Severe COPD Marketed Products Heat Map, Safety, 2016 33
  • Figure 4: COPD Market, Global, Very Severe COPD Marketed Products Heat Map, Efficacy, 2016 34
  • Figure 5: COPD Market, Global, Very Severe COPD Marketed Products Heat Map, Safety, 2016 35
  • Figure 6: COPD Therapeutics
Read More
  • 1.1 List of Tables
  • Table 1: COPD Therapeutics Market, Global, All Pipeline Products, Discovery, 2016 98
  • Table 2: COPD Therapeutics Market, Global, All Pipeline Products, Preclinical, 2016 100
  • Table 3: COPD Therapeutics Market, Global, All Pipeline Products, Phase I, 2016 103
  • Table 4: COPD Therapeutics Market, Global, All Pipeline Products, Phase II, 2016 104
  • Table 5: COPD Therapeutics Market, Global, All Pipeline Products, Phase III, 2016 105
  • Table 6: COPD Therapeutics Market, Global, All Pipeli
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 8
  • 1.2 List of Figures 8
  • 2 Introduction 10
  • 2.1 Disease Introduction 10
  • 2.2 Epidemiology 10
  • 2.3 Symptoms 11
  • 2.4 Etiology and Pathophysiology 12
  • 2.4.1 Pathophysiology 13
  • 2.5 Diagnosis 13
  • 2.6 Disease Stages 14
  • 2.7 Prognosis 14
  • 2.8 Treatment Options 15
  • 2.8.1 Treatment Algorithm 16
  • 3 Marketed Products 18
  • 3.1 Overview 18
  • 3.2 Bronchodilator Combination Therapy 18
  • 3.2.1 Brimica/Duaklir Genuair (aclidinium/formoterol) - AstraZeneca 18
  • 3.2.2 Spio
Read More

Please select a license type

Share

Related Products

GBI ResearchCOPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel TherapiesProduct ThumbnailCOPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies, Industry ReportProduct #: 631437
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved